National Cancer Institute U.S. National Institutes of Health | www.cancer.gov
SPORES Logo - Translational Research, Clinical, Pre-Clinical, Basic, Pre-Clinical SPOREs - Specialized Programs of Research Excellence
Home Organization of the OSB Organ-Specific SPORE Programs Information for the Public Patient Advocate Research Team Information for Applicants Address and Directions IntraSPORE Communications  

[ SPOREs: Brain | Breast | GI | GU | GYN | Head and Neck | Leukemia | Lung | Lymphoma | Myeloma | Ovarian | Pancreatic | Prostate | Skin ]

Leukemia SPOREs

Despite the fact that major advances in diagnosis and treatment were achieved in the last 50 years, especially in childhood leukemia, this group of diseases remains to be a serious medical problem. According to the American Cancer Society, 35,070 new cases are expected in the United States in 2006 approximately evenly divided between acute and chronic types. An estimated 22,280 people will die of leukemia in the same year. An interesting decline of incidence and deaths was observed after the mid-1990s with a rate of 3-4% per year. The first round of applications in Leukemia SPOREs took place in the year 2002, with the subsequent establishment of the first Leukemia SPORE in 2003. This SPORE was named in honor of the late congressman Joe Moakley.

To view the associated abstract, click on the name/address below.

Jean Pierre Issa, MD
Associate Professor
Department of Leukemia
University of Texas M.D. Anderson Cancer Center
1515 Holcombe Boulevard, Unit 428
Houston, TX 77030
Tel: (713) 745-2260
Fax: (713) 746-1683

For more information on this specific SPORE's institution, please visit: http://www.mdanderson.org/departments/leukemiaspore/

 


National Cancer Institute Department of Health and Human Services National Institutes of Health FirstGov.gov